Global RNA Analysis Market to grow with a CAGR of 9.60%
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Global RNA Analysis Market.
According
to TechSci Research report, “Global RNA Analysis Market Industry Size,
Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global RNA Analysis Market has
valued at USD 8.30 billion in 2022 and is anticipated to witness an impressive
growth in the forecast period with a CAGR of 9.60% through 2028. This can be due to collaborations and
partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market. The emergence of RNA therapeutics is a significant driver of demand for
RNA analysis technologies in the Global RNA Analysis Market. RNA-based
therapies have gained momentum in recent years as a promising approach to treat
a wide range of diseases, including genetic disorders, cancer, infectious
diseases, and rare diseases. RNA analysis techniques, such as RNA sequencing
(RNA-Seq) and quantitative PCR (qPCR), are essential for the discovery and
development of RNA-based therapeutics. Researchers use RNA analysis to identify
potential therapeutic targets, assess gene expression changes in disease
states, and validate the effects of RNA drugs. The rapid development and
authorization of mRNA vaccines, such as those for COVID-19, have highlighted
the potential of mRNA-based therapeutics. RNA analysis is instrumental in
vaccine development, including assessing mRNA stability, expression levels, and
immune response. RNA analysis identifies disease-associated RNA molecules, such
as non-coding RNAs (e.g., microRNAs and long non-coding RNAs) and dysregulated
protein-coding RNAs, that can serve as therapeutic targets. Validating these
targets is essential for drug development. RNA analysis facilitates the
discovery of RNA biomarkers that can predict disease progression, treatment
response, and patient outcomes. These biomarkers play a crucial role in patient
stratification and personalized medicine.
Browse
over XX market data Figures and spread through 110
Pages and an in-depth TOC on " Global RNA Analysis Market.”
The
COVID-19 pandemic's start had a big effect on the market under investigation.
Following the severity of the infection caused by the SARS-CoV-2 virus, the
pandemic epidemic raised the need for testing and diagnosis. Research efforts
to understand the genetics of the virus have expanded. so that researchers can
develop a powerful vaccine to treat the illness. In
May 2023, Twist Bioscience Corporation, a business that helps customers succeed
by providing high-quality synthetic DNA using its silicon platform, has
introduced a portfolio of RNA sequencing tools, including the Twist RNA Exome,
Twist RNA Library Prep Kit, and the Twist Ribosomal RNA (rRNA) &
Haemoglobin (Globin) Depletion Kit. The company also offers custom target
enrichment capabilities for RNA and whole transcriptome sequencing. Precision
medicine, the hunt for biomarkers, and studies in immuno-oncology can all
benefit from the focused or entire transcriptome analysis that this complete
set of RNA tools can facilitate. Twist target enrichment for RNA takes use of
Twist target enrichment's performance, effectiveness, and sensitivity for
sequencing important RNA transcripts across samples and species. With the RNA
Exome or in customised RNA panels, it may be utilised to enrich pertinent
transcripts.
Standardization
and quality control are significant challenges in the Global RNA Analysis
Market. Ensuring the accuracy, reproducibility, and comparability of RNA
analysis data across laboratories and experiments is critical for meaningful
scientific and clinical outcomes. Variability in sample collection,
preservation, and handling procedures can significantly impact RNA quality and
integrity. Standardized protocols and best practices are needed to minimize
pre-analytical variability. The choice of RNA extraction method and kit can
affect RNA yield and quality. Standardized extraction protocols and quality
control measures are essential to ensure consistent results. The availability
of well-characterized reference materials (e.g., RNA standards) can aid in
standardization efforts by serving as controls for quality control and assay
performance. Library preparation protocols can introduce biases and variability
in RNA-Seq data. Standardized library preparation methods and quality control
steps, such as adapter trimming and size selection, are critical.
Global RNA Analysis Market segmentation is based on Product, Technology, Application, End User, and
Region. Based on Application,
Global RNA Analysis Market is segmented into Epigenetics, Infectious Diseases
& Pathogenesis, Alternative RNA Splicing, RNA Structure & Molecular
Dynamics, Development & Delivery of RNA Therapeutics. RNA analysis
plays a crucial role in epigenetics, a field of biology that explores heritable
changes in gene expression and regulation that do not involve alterations to
the DNA sequence itself. Epigenetic modifications can be reversible and are
influenced by various factors, including environmental exposures and cellular
processes. Epitranscriptomics is the study of RNA modifications, which are
chemical changes to RNA molecules that can affect gene expression and function.
Some of the most well-known RNA modifications include m6A (N6-methyladenosine)
and 5-methylcytosine (m5C). RNA analysis techniques, such as RNA-Seq and mass
spectrometry, are used to identify and quantify RNA modifications. Researchers
investigate how these modifications impact RNA stability, translation, and the
regulation of gene expression.
Based on Region, North America dominated the Global RNA Analysis Market.
The region's advanced healthcare infrastructure and research institutions have
allowed for the rapid adoption of RNA analysis in clinical and diagnostic
applications. This includes using RNA-based tests for cancer diagnosis,
monitoring treatment responses, and studying infectious diseases. North
American universities and research institutions have been at the forefront of
RNA-related research. Academic researchers in the region have made significant
contributions to the development of RNA analysis techniques and their
applications. Next-generation sequencing (NGS) technologies, essential for RNA
analysis, are readily available and widely adopted in North America. Access to
state-of-the-art sequencing platforms accelerates research in genomics and
transcriptomics. North American researchers and institutions actively
collaborate with each other and with international partners. These
collaborations facilitate the exchange of knowledge and expertise in RNA
analysis.
Asia-pacific region to witness fastest growth in the
Global RNA Analysis Market. The
Asia-Pacific region includes several emerging markets with large populations,
creating a substantial patient pool for clinical research and diagnostics. As
healthcare infrastructure and research capabilities improve, there is a growing
demand for RNA analysis technologies to support research, disease diagnosis,
and personalized medicine approaches. The region, particularly countries like
China, India, South Korea, and Singapore, has experienced significant growth in
its biotechnology and pharmaceutical sectors. This growth is driven by
government investments, increasing R&D activities, and a focus on
developing innovative therapies. RNA analysis is a critical component of drug
discovery and development, making it an integral part of the region's expanding
life sciences industry. The Asia-Pacific region has a rising burden of various
diseases, including cancer, infectious diseases, and chronic conditions. RNA
analysis plays a crucial role in disease diagnosis, biomarker discovery, and
the development of targeted therapies.
Some of the major companies
operating in the Global RNA Analysis Market
include:
- Agilent
Technologies, Inc.
- F.
Hoffmann-La Roche AG
- Illumina,
Inc.
- QIAGEN
- Thermo
Fisher Scientific, Inc.
- Eurofins
Scientific
- Merck
KGaA
- Bio-Rad
Laboratories, Inc.
- Pacific
Bioscience of California, Inc.
- Affymetrix,
Inc.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“Certain areas, particularly in North
America, are projected to exert significant demand for RNA analysis. The growth
in the competitive landscape and the presence of well-established companies in
the market, committed to enhance the overall wellbeing of people each year, are
expected to contribute to a remarkable growth of the Global RNA Analysis Market
in the forecast period," said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based Global management consulting firm.
RNA Analysis Market – Global Industry Size, Share, Segmented by Product (Kits & Reagents, Services, Instruments), By Technology (Real Time-PCR (qPCR), Microarray, Sequencing, others), By Application (Epigenetics, Infectious Diseases & Pathogenesis, Alternative RNA Splicing, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics), By End-use (Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, others), by region, and Competition, Opportunity, & Forecast" has evaluated the future growth potential of
Global RNA Analysis Market and provides statistics & information on market
size, structure, and future market growth. The report intends to provide innovative
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global RNA Analysis Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com